A placebo-controlled, dose-response study of dexfenfluramine in the treatment of obese patients

Current Therapeutic Research - Clinical and Experimental

Volumn 57, Issue 9, 1996, Pages 663-674

  Marbury, Thomas C ^a   Angelo, John E ^b   Michael Gulley, R ^c   Krosnick, Arthur ^d   Sugimoto, Danny H ^e   Zellner, Stephen R ^f  

^a ORLANDO CLINICAL RESEARCH CENTER   (United States)

^b Urologic Institute of New Orleans   (United States)

^c Princeton Diabetes Treatment and Education Center ^*  (United States)

^d Princeton Diabet Treatm Educ Ctr   (United States)

^e RADIANT RESEARCH   (United States)

^f Internal Medicine Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXFENFLURAMINE; NORFENFLURAMINE; PLACEBO;

ADULT; ARTICLE; ASTHENIA; BODY WEIGHT; CALORIC INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; VERTIGO; WEIGHT REDUCTION; XEROSTOMIA;

EID: 0029849924     PISSN: 0011393x     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(96)80071-3     Document Type: Article

References (14)

1. Appetite suppressants. A review
2. Drug therapy after very-low-calorie diets
3. Efficacy and safety of dexfenfluramine in obese patients: A multicenter study
4. Effect of 6 months therapy with dexfenfluramine in obese patients: Studies in the United Kingdom
5. International trial of long-term dexfenfluramine in obesity
6. Dexfenfluramine as adjuvant to a low-calorie formula diet in the treatment of obesity: A randomized clinical trial
7. Effect of dexfenfluramine treatment on body weight, blood pressure and noradrenergic activity in obese hypertensive patients
8. Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity
9. A six-month study of the effects of dexfenfluramine on partially successful dieters
10. Metropolitan height and weight tables
11. Evaluation of three anorexiants: Clortermine hydrochloride (Voranil), fenfluramine hydrochloride (Pondimin), and maxindol (Sanorec)
12. Drugs of dependence though not of abuse: Fenfluramine and imipramine
13. Comparison of medically supervised and unsupervised approaches to weight loss and control
14. Haemodynamic, metabolic and endocrine effects of short-term dexfenfluramine treatment in young, obese women